<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01336400</url>
  </required_header>
  <id_info>
    <org_study_id>IWT-TBM-090878</org_study_id>
    <nct_id>NCT01336400</nct_id>
  </id_info>
  <brief_title>Genome-wide Single Cell Haplotyping as a Generic Method for Preimplantation Genetic Diagnosis</brief_title>
  <official_title>Genome-wide Single Cell Haplotyping as a Generic Method for Preimplantation Genetic Diagnosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vrije Universiteit Brussel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators previously developed approaches to SNP-, CNV- and haplo-type single human
      cells (Vanneste et al. 2009, Nature Medicine). These methods open the possibility to be
      developed into a novel generic diagnostic technique which broadens the spectrum of
      disease-alleles that can be selected against during preimplantation genetic diagnosis (PGD)
      and which enables to help those couples that cannot be supported by PGD yet. PGD is the
      genetic analysis of a single blastomere from an in vitro fertilized (IVF) embryo and it is
      offered to couples to avoid the transmission of heritable genetic disorders to their
      offspring. PGD analyses are performed for (1) autosomal dominant or recessive monogenic
      diseases, (2) X-linked disorders and (3) chromosomal aberrations that may result in aneuploid
      conceptions. This novel method is likely to outperform and hence, replace current techniques
      for preimplantation genetic diagnosis. In this project the investigators will bring the
      technology from a proof-of-principle to the clinical application. To this end the
      investigators will make computational improvements for accurate single blastomere SNP-, CNV-
      and haplo-typing and perform a large validation study. For the validation studythe
      investigators will analyse the genomes of the blastomeres derived from 60 spare embryos of
      different origin: (1) Embryos diagnosed as genetically abnormal using current PCR- and
      FISH-protocols. (2) Embryos diagnosed as normal for the investigated region using current
      PCR- and FISH-protocols, but not of sufficient quality to be transferred or frozen. (3)
      Embryos of the sex that is selected against following PGD based sex-selection, or embryos of
      the sex that is selected for but of insufficient quality to be transferred or frozen. (4)
      Embryos that were not biopsied in a PGD cycle since they suffer a slight growth delay. This
      validation study will allow us to evaluate (1) the clinical validity (false positive and
      negative rate) and (2) clinical applicability (in terms of ease of use, success rate, etc.).
      In addition, it will bring us essential further fundamental insights in the origins and
      mechanisms of chromosomal instability operating during early embryogenesis and its
      consequences for clinical applications of PGD. Finally, following the validation study, this
      project will clinically implement the technique to treat 10 families.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">September 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Preimplantation Genetic Diagnosis</condition>
  <arm_group>
    <arm_group_label>PGD-FISH</arm_group_label>
    <description>Following couples opting for preimplantation genetic diagnosis on the basis of FISH:
couples suffering a complex chromosomal rearrangement (CCR)
couples with X-linked recessive disorders
couples that carry a balanced chromosomal rearrangement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PGD-PCR</arm_group_label>
    <description>Following couples opting for preimplantation genetic diagnosis on the basis of PCR:
-couples at risk for the transmission of monogenic diseases</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>single cell haplotyping</intervention_name>
    <description>We aim to collect single blastomeres from spare IVF embryos of 30 couples to optimize and test methods for single cell haplotyping. We aim to collect 20 and 10 couples coming to the fertility centre for FISH- or PCR-based PGD respectively. In both groups, at least 5 different indications for PGD will be collected. Per couple, we will perform 10 SNP-arrays: 2 for the couple donating the embryo, 4 for family members (often parents of the couple) and 4 for blastomeres since we aim to pick 2 cells from 2 embryos per couple. For five couples, 2 blastomeres of all available embryos will be aspirated to validate and optimize the phasing methods. Finally, for some embryos, all blastomeres will be picked to be able to prove the reproducibility of single cell haplotyping.</description>
    <arm_group_label>PGD-FISH</arm_group_label>
    <arm_group_label>PGD-PCR</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Genomic DNA, single blastomere DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        We aim to collect spare embryos of 30 couples that opt for preimplantation genetic
        diagnosis (see Eligibility Criteria).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Blastomeres biopsied from spare embryos ((A) Embryos diagnosed as genetically abnormal
        using current PCR- and FISH-protocols; (B) Embryos diagnosed as normal for the investigated
        region using current PCR- and FISH-protocols, but not of sufficient quality to be
        transferred or frozen; (C) Embryos of the sex that is selected against following PGD based
        sex-selection, or embryos of the sex that is selected for but of insufficient quality to be
        transferred or frozen; (D) Embryos that were not biopsied in a PGD cycle since they suffer
        a slight growth delay.) derived from following patient groups:

          1. The first patient group involve couples suffering a complex chromosomal rearrangement
             (CCR), which is defined as a structural chromosomal rearrangement with at least three
             breakpoints and an exchange of genetic material between two or more chromosomes.

          2. The second patient group involve couples with X-linked recessive disorders.

          3. The third patient group consists of couples that carry a balanced chromosomal
             rearrangement - a translocation, insertion or inversion - that may result in recurrent
             miscarriage or aneuploid, severely handicapped offspring.

          4. A fourth patient group are couples at risk for the transmission of monogenic diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joris R Vermeesch, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thierry Voet, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholieke Universiteit Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas D'Hooghe, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yves Moreau, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholieke Universiteit Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karen Sermon, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vrije Universiteit Brussel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>De Rycke Martine, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joris R Vermeesch, Professor</last_name>
    <phone>+32 16 345941</phone>
    <email>Joris.Vermeesch@uzleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thierry Voet, Professor</last_name>
    <phone>+32 16 347991</phone>
    <email>Thierry.Voet@med.kuleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitaire Ziekenhuizen Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joris R Vermeesch, Professor</last_name>
      <phone>+32 16 345941</phone>
      <email>Joris.Vermeesch@uzleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Thierry Voet, Professor</last_name>
      <phone>+32 16 347991</phone>
      <email>Thierry.Voet@med.kuleuven.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Vanneste E, Voet T, Le Caignec C, Ampe M, Konings P, Melotte C, Debrock S, Amyere M, Vikkula M, Schuit F, Fryns JP, Verbeke G, D'Hooghe T, Moreau Y, Vermeesch JR. Chromosome instability is common in human cleavage-stage embryos. Nat Med. 2009 May;15(5):577-83. doi: 10.1038/nm.1924. Epub 2009 Apr 26.</citation>
    <PMID>19396175</PMID>
  </reference>
  <reference>
    <citation>Vanneste E, Voet T, Melotte C, Debrock S, Sermon K, Staessen C, Liebaers I, Fryns JP, D'Hooghe T, Vermeesch JR. What next for preimplantation genetic screening? High mitotic chromosome instability rate provides the biological basis for the low success rate. Hum Reprod. 2009 Nov;24(11):2679-82. doi: 10.1093/humrep/dep266. Epub 2009 Jul 24.</citation>
    <PMID>19633308</PMID>
  </reference>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2011</study_first_submitted>
  <study_first_submitted_qc>April 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2011</study_first_posted>
  <last_update_submitted>April 14, 2011</last_update_submitted>
  <last_update_submitted_qc>April 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2011</last_update_posted>
  <responsible_party>
    <name_title>Professor Joris Vermeesch</name_title>
    <organization>Universitaire Ziekenhuizen Leuven</organization>
  </responsible_party>
  <keyword>Single cell haplotyping</keyword>
  <keyword>Preimplantation genetic diagnosis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

